Rabeprazole for Clinical Trials

This trial tests a new form of a medication to compare its absorption in the body with the current version. It also examines the effects of a high-fat meal or a stomach acid reducer (such as rabeprazole) on the medication's absorption. This study is ideal for healthy individuals without significant medical conditions or drug allergies. The results will help determine the best way to administer the medication in future studies. As a Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this new medication.

Yes, you will need to stop taking most prescription and nonprescription drugs, as well as dietary and herbal supplements, at least 7 days or 5 half-lives before the first dose of the study drug. Proton pump inhibitors and certain other medications have specific restrictions, so it's important to discuss your current medications with the study team.

Research has shown that rabeprazole is generally safe for most people. Side effects are usually mild and can include headaches, diarrhea, and stomach pain. These occur in a small number of people, with headaches affecting up to 10% of users. Other possible side effects include nausea, constipation, and gas. Serious side effects are rare, but if any symptoms become bothersome, consulting a doctor is important. Overall, rabeprazole is considered safe, especially since the FDA has approved it for other conditions related to reducing stomach acid.¹²³⁴⁵

Researchers are excited about these treatments because they explore Rabeprazole's potential to enhance the effectiveness of PF-07799933, particularly when used in combination with PF-07799544. Rabeprazole, a proton pump inhibitor, is commonly used to reduce stomach acid, potentially improving the absorption and efficacy of PF-07799933. Unlike standard treatments that may not consider such interactions, this trial investigates how timing and conditions, like fasting or fed states, impact the drug's performance. By fine-tuning these variables, the study aims to optimize treatment outcomes, paving the way for potentially more effective therapeutic strategies.

Rabeprazole treats problems caused by stomach acid, such as heartburn and stomach ulcers. Studies have shown that about 95% of people taking rabeprazole experience no symptoms after long-term use. This medication reduces stomach acid production, preventing ulcers and easing acid reflux symptoms. Research involving over 1,000 patients found rabeprazole safe and effective for managing gastroesophageal reflux disease (GERD). Doctors regard rabeprazole highly for its ability to manage and prevent issues related to stomach acid. In this trial, one treatment arm involves participants receiving PF-07799933 film-coated tablets following rabeprazole pretreatment.⁶⁷⁸⁹¹⁰